Vera Therapeutics, Inc.
VERA
Revenue
0.00
0.000.00%
-Assets
397.29M
▼-22.07M▼-5.26%
3 Months ChangeLiabilities
69.42M
▲3.61M▲5.48%
3 Months ChangeFree Cash Flow
-26.29M
▼-17.29M▼-192.17%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 8-K
ID: 0001193125-24-248079
2024-10-28
Form 8-K
ID: 0001193125-24-245704
2024-10-02
Form 8-K
ID: 0001193125-24-230760
2024-08-08
Form 10-Q
ID: 0000950170-24-094108
2024-08-08
Form 8-K
ID: 0000950170-24-093342
2024-07-02
Form 8-K
ID: 0001193125-24-174318
2024-06-12
Form 8-K
ID: 0001193125-24-159935
2024-05-17
Form 8-K
ID: 0000950170-24-061872
2024-05-10
Form 10-Q
ID: 0000950170-24-057292
2024-05-09
Form 8-K
ID: 0000950170-24-056283